This inventor holds 5 USPTO granted patents, plus 3 CIPO patents and 3 EPO patents. Top assignee: Daewoong Co., Ltd.. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Kyoung-Yun Kim: Innovator in Botulinum Toxin Production
Introduction
Kyoung-Yun Kim is a prominent inventor based in Jeollabuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of botulinum toxin. With a total of 5 patents to his name, Kim's work has the potential to impact various medical and industrial applications.
Latest Patents
Kyoung-Yun Kim's latest patents include innovative methods for producing botulinum toxin. One notable patent describes a method that involves treating a culture of a botulinum toxin-producing strain with acid to form a precipitate. This process is followed by clarification using various filtration methods and anion-exchange chromatography to purify the toxin. Another patent focuses on a medium composition for culturing bacteria capable of producing botulinum toxin. This medium includes plant-derived peptones, which enhance the growth rate of the bacteria and prevent contamination from animal-derived components.
Career Highlights
Kyoung-Yun Kim is currently associated with Daewoong Co., Ltd., where he continues to advance his research in biotechnology. His work has garnered attention for its innovative approaches to toxin production, which could lead to safer and more efficient methods in the industry.
Collaborations
Kim collaborates with notable colleagues, including Hye-Young Sul and Kyoung-Min Min. Their combined expertise contributes to the success of their research initiatives and the development of new technologies in the field.
Conclusion
Kyoung-Yun Kim's contributions to the production of botulinum toxin exemplify the importance of innovation in biotechnology. His patents and ongoing research hold promise for advancements in medical and industrial applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
